Human monoclonal antibodies against West Nile virus from Japanese encephalitis-vaccinated volunteers. 2018

Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.

West Nile virus (WNV) is a positive-sense single-stranded RNA flavivirus belonging to the Japanese encephalitis virus (JEV) serocomplex of the Flaviviridae family and causes mosquito-borne infections. Although most human infection cases are asymptomatic, approximately one in 150 infected individuals develops meningoencephalitis, with a mortality rate of 4-14%. While the development of human neutralizing antibody therapeutics against WNV is strongly anticipated, WNV is difficult to study in conventional laboratories due to its high safety level requirement. In this study, we established fully human WNV-neutralizing monoclonal antibodies from the peripheral blood mononuclear cells of inactivated-JEV-vaccinated individuals, and these antibodies exhibited WNV neutralization both in vitro and in vivo. Our results demonstrate a new antibody cross-reactivity strategy to develop immunological therapeutic reagents for WNV and other JEV serotype viruses.

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004664 Encephalitis Virus, Japanese A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent. Japanese B Encephalitis Virus,Japanese Encephalitis Virus,Virus, Japanese Encephalitis
D004672 Encephalitis, Japanese A mosquito-borne encephalitis caused by the Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE) occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits (including a POLIOMYELITIS-like presentation); SEIZURES; COMA; and death. (From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351(9109):1094-7) Encephalitis, Japanese B,Japanese Encephalitis,Japanese B Encephalitis,Japanese B Viral Encephalitis,Viral Encephalitis, Japanese B
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
August 1986, The Indian journal of medical research,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
October 2021, mBio,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
October 1982, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
April 2015, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
March 2010, The Journal of veterinary medical science,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
September 2023, Infectious medicine,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
January 2008, Acta virologica,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
January 2005, Vector borne and zoonotic diseases (Larchmont, N.Y.),
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
December 2013, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Tatsuhiko Ozawa, and Hideyuki Masaki, and Tomohiko Takasaki, and Ikuko Aoyama, and Takahiro Yumisashi, and Atsushi Yamanaka, and Eiji Konishi, and Yoh Ohnuki, and Atsushi Muraguchi, and Hiroyuki Kishi
February 1982, The Journal of general virology,
Copied contents to your clipboard!